Michael Leuchten
Stock Analyst at Jefferies
(0.40)
# 4,239
Out of 4,574 analysts
563
Total ratings
50.4%
Success rate
-3.7%
Average return
Main Sectors:
Stocks Rated by Michael Leuchten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: AZN AstraZeneca PLC | Maintained: Buy | 17,500p | 12,670p | +38.12% | 100 | Jul 22, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Hold | CHF 90.00 → CHF 110.00 | CHF 126.90 | -13.32% | 12 | Jul 21, 2026 | |
| LON: GSK GSK plc | Maintained: Buy | 2,500p | 1,920p | +30.24% | 45 | Jul 17, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Maintained: Hold | €46.00 | €46.06 | -0.13% | 94 | Jul 13, 2026 | |
| EPA: SAN Sanofi | Maintained: Buy | €100.00 | €76.03 | +31.53% | 20 | Jul 2, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 270.00 → kr 285.00 | kr 320.60 | -11.10% | 71 | Jun 30, 2026 | |
| LON: 0NZT UCB SA | Maintained: Sell | €212.00 | €240.88 | -11.99% | 2 | Jun 22, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Sell | CHF 230.00 | CHF 355.10 | -35.23% | 70 | Jun 8, 2026 | |
| GSK GSK plc | Maintained: Buy | $56 → $67 | $51.35 | +30.67% | 4 | May 29, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Buy | €470.00 | €221.00 | n/a | 42 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €208.00 | €139.15 | n/a | 40 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €108.00 → €113.00 | €158.40 | n/a | 11 | Jun 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €420.00 → €390.00 | €167.30 | n/a | 10 | Jun 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 2,650p | 3,306p | n/a | 1 | Oct 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $48.77 | n/a | 20 | Jun 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €400.00 | €174.00 | n/a | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €83.00 → €80.00 | €43.27 | n/a | 4 | Nov 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €40.00 → €45.00 | €43.80 | n/a | 2 | Nov 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 75.00 → CHF 85.00 | CHF 55.74 | n/a | 6 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $43.35 | n/a | 1 | May 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $155.01 | n/a | 2 | Apr 22, 2016 |
AstraZeneca PLC
Jul 22, 2026
Maintained: Buy
Price Target: 17,500p
Current: 12,670p
Upside: +38.12%
Novartis AG
Jul 21, 2026
Maintained: Hold
Price Target: CHF 90.00 → CHF 110.00
Current: CHF 126.90
Upside: -13.32%
GSK plc
Jul 17, 2026
Maintained: Buy
Price Target: 2,500p
Current: 1,920p
Upside: +30.24%
Bayer Aktiengesellschaft
Jul 13, 2026
Maintained: Hold
Price Target: €46.00
Current: €46.06
Upside: -0.13%
Sanofi
Jul 2, 2026
Maintained: Buy
Price Target: €100.00
Current: €76.03
Upside: +31.53%
Novo Nordisk A/S
Jun 30, 2026
Maintained: Hold
Price Target: kr 270.00 → kr 285.00
Current: kr 320.60
Upside: -11.10%
UCB SA
Jun 22, 2026
Maintained: Sell
Price Target: €212.00
Current: €240.88
Upside: -11.99%
Roche Holding AG
Jun 8, 2026
Maintained: Sell
Price Target: CHF 230.00
Current: CHF 355.10
Upside: -35.23%
GSK plc
May 29, 2026
Maintained: Buy
Price Target: $56 → $67
Current: $51.35
Upside: +30.67%
Sartorius Aktiengesellschaft
Aug 21, 2023
Maintained: Buy
Price Target: €470.00
Current: €221.00
Upside: n/a
Aug 4, 2023
Maintained: Buy
Price Target: €208.00
Current: €139.15
Upside: n/a
Jun 30, 2023
Maintained: Hold
Price Target: €108.00 → €113.00
Current: €158.40
Upside: n/a
Jun 19, 2023
Maintained: Buy
Price Target: €420.00 → €390.00
Current: €167.30
Upside: n/a
Oct 10, 2022
Maintained: Buy
Price Target: 2,650p
Current: 3,306p
Upside: n/a
Jun 28, 2022
Downgraded: Sell
Price Target: n/a
Current: $48.77
Upside: n/a
Feb 28, 2022
Maintained: Sell
Price Target: €400.00
Current: €174.00
Upside: n/a
Nov 4, 2021
Maintained: Buy
Price Target: €83.00 → €80.00
Current: €43.27
Upside: n/a
Nov 2, 2021
Maintained: Hold
Price Target: €40.00 → €45.00
Current: €43.80
Upside: n/a
Aug 23, 2021
Maintained: Buy
Price Target: CHF 75.00 → CHF 85.00
Current: CHF 55.74
Upside: n/a
May 12, 2016
Upgraded: Buy
Price Target: n/a
Current: $43.35
Upside: n/a
Apr 22, 2016
Upgraded: Hold
Price Target: n/a
Current: $155.01
Upside: n/a